ALKBH4 and neoplasm: In contrast, in colorectal cancer (CRC), ALKBH4 acts as a tumor suppressor, inhibiting the invasive and metastatic ability of CRC cells by inhibiting epithelial-mesenchymal transition (EMT) [54].